Reference List
AACR, Cancer Health Disparities. Accessed from https://www.aacr.org/patients-caregivers/about-cancer/cancer-health-disparities/ on October 6, 2021.
Andermann A. Taking action on the social determinants of health in clinical practice: a framework for health professionals. CMAJ. 2016;188(17-18):E474-E483. doi:10.1503/cmaj.160177
Andermann A. Screening for social determinants of health in clinical care: moving from the margins to the mainstream. Public Health Rev. 2018;39:19. doi:10.1186/s40985-018-0094-7
Cloyes KG, Hull W, Davis A. Palliative and End-of-Life Care for Lesbian, Gay, Bisexual, and Transgender (LGBT) Cancer Patients and Their Caregivers. Semin Oncol Nurs. 2018;34(1):60-71. doi:10.1016/j.soncn.2017.12.003
Fenton, Health Care’s Blind Side. Accessed from https://www.rwjf.org/en/library/research/2011/12/health-care-s-blind-side.html on February 2, 2022
FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19. doi:10.1186/s12910-017-0179-8
Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24. doi:10.1186/s13293-020-00301-y
LaForge K, Gold R, Cottrell E, et al. How 6 Organizations Developed Tools and Processes for Social Determinants of Health Screening in Primary Care: An Overview. J Ambul Care Manage. 2018;41(1):2-14. doi:10.1097/JAC.0000000000000221
Li D, Duan H, Jiang P, et al. Trend and socioeconomic disparities in survival outcome of metastatic melanoma after approval of immune checkpoint inhibitors: a population-based study. Am J Transl Res. 2020;12(7):3767-3779.
Nazha B, Mishra M, Pentz R, Owonikoko TK. Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy. Am Soc Clin Oncol Educ Book. 2019;39:3-10. doi:10.1200/EDBK_100021
O’Connor JM, Seidl-Rathkopf K, Torres AZ, et al. Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors. Oncologist. 2018;23(11):1388-1390. doi:10.1634/theoncologist.2017-0673
Parikh AB, Zhong X, Mellgard G, et al. Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy. Am J Clin Oncol. 2021;44(3):114-120. doi:10.1097/COC.0000000000000793
Sawchuk CN, Van Dyke E, Omidpanah A, Russo JE, Tsosie U, Buchwald D. Caregiving among American Indians and Alaska Natives with cancer. Support Care Cancer. 2015;23(6):1607-1614. doi:10.1007/s00520-014-2512-9
Taylor LA, Tan AX, Coyle CE, et al. Leveraging the Social Determinants of Health: What Works?. PLoS One. 2016;11(8):e0160217. doi:10.1371/journal.pone.0160217
Thompson LL, Pan CX, Chang MS, Krasnow NA, Blum AE, Chen ST. Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors. J Am Acad Dermatol. 2021;84(3):851-854. doi:10.1016/j.jaad.2020.09.096
Thornton R, Glover C, Cene C, Glik D, et al. Evaluating strategies for reducing health disparities by addressing the social determinants of health. Health Aff (Millwood), 35(8):1416-23. doi: 10.1377/hlthaff.2015.1357
Tripathi R, Archibald LK, Mazmudar RS, et al. Racial differences in time to treatment for melanoma. J Am Acad Dermatol. 2020;83(3):854-859. doi:10.1016/j.jaad.2020.03.094
van Ryn M, Burgess DJ, Dovidio JF, et al. The impact of racism on clinician cognition, behavior, and clinical decision making. Du Bois Rev. 2011;8(1):199-218. doi:10.1017/S1742058X11000191
WHO, Social determinants of health. Accessed from https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1 on February 2, 2022
Williams DR, Priest N, Anderson NB. Understanding associations among race, socioeconomic status, and health: Patterns and prospects. Health Psychol. 2016;35(4):407-411. doi:10.1037/hea0000242
Resource List
